Display options
Cite
Jalali A, Ebrahimi H, Ohadi M, et al. New Variations in the Promoter Regions of Human DOCK4 and RAP1A Genes, and Coding Regions of RAP1A in Sporadic Breast Tumors. Avicenna J Med Biotechnol. 2009;1(2):117-23
Jalali, A., Ebrahimi, H., Ohadi, M., Karimloo, M., Shemirani, A. I., Mohajer, B., & Khorshid, H. R. (2009). New Variations in the Promoter Regions of Human DOCK4 and RAP1A Genes, and Coding Regions of RAP1A in Sporadic Breast Tumors. Avicenna journal of medical biotechnology, 1(2), 117-23.
Jalali, Akram, et al. "New Variations in the Promoter Regions of Human DOCK4 and RAP1A Genes, and Coding Regions of RAP1A in Sporadic Breast Tumors." Avicenna journal of medical biotechnology vol. 1,2 (2009): 117-23.
Jalali A, Ebrahimi H, Ohadi M, Karimloo M, Shemirani AI, Mohajer B, Khorshid HR. New Variations in the Promoter Regions of Human DOCK4 and RAP1A Genes, and Coding Regions of RAP1A in Sporadic Breast Tumors. Avicenna J Med Biotechnol. 2009 Jul;1(2):117-23. PMID: 23407849; PMCID: PMC3558130.
Copy Download .nbib Format: NLM
Share it on

Avicenna J Med Biotechnol. 2009 Jul;1(2):117-23.

New Variations in the Promoter Regions of Human DOCK4 and RAP1A Genes, and Coding Regions of RAP1A in Sporadic Breast Tumors.

Avicenna journal of medical biotechnology

Akram Jalali, Hassan Ebrahimi, Mina Ohadi, Masood Karimloo, Atena Irani Shemirani, Behrokh Mohajer, Hamid Reza Khorram Khorshid

Affiliations

  1. Genetic Research Centre, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

PMID: 23407849 PMCID: PMC3558130

Abstract

Breast cancer is the most common cancer among women in developed countries. The prevalence of the disease is increasing in the world. Its annual incidence among Iranian women is about 7000 cases. RAP1A, a tumor suppressor gene, is located at 1p13.3 and plays an important role in the cellular adhesion pathway and is involved in the pathogenesis of breast cancer. The DOCK4 gene, which is located at 7q31.1, specifically activates RAP1A gene. In the present study, DNA samples from 64 cases of sporadic breast tumors (referred to Mehrad Hospital in Tehran) were screened using PCR-SSCP method and the number of observed variations compared with the control group (100 normal women). Mutation detection for coding exons of RAP1A gene and the 500 bp upstream of transcription initiation site as promoters of both DOCK4 and RAP1A were carried out and compared with the control group. The promoter region of DOCK4 showed a heterozygous mutation with G>A transition at nucleotide -303 in a fibroadenoma case. With regard to RAP1A we found a heterozygous mutation, G>A transition in an adenoid cystic carcinoma case, and another heterozygous mutation, G>T transversion in an intraductal papilloma case both at nucleotide +45. A homozygous variation, T>A transversion was also found at nucleotide +29 of a fibroadenoma case. The differences in the frequency of variations mentioned above were not statistically significant. However Fisher's exact showed significant difference for T>A transversion. Although, the higher frequency of these mutations and variations may be related to the disease, a larger sample size is needed for the confirmation of our findings.

Keywords: DOCK4; Loss of heterozygosity (LOH); PCR-SSCP; RAP1A; Sporadic breast tumor

References

  1. Genes Chromosomes Cancer. 1999 Mar;24(3):255-63 - PubMed
  2. J Biol Chem. 2004 Aug 20;279(34):35127-32 - PubMed
  3. Gynakol Geburtshilfliche Rundsch. 1995;35 Suppl 1:63-7 - PubMed
  4. Breast J. 2007 Jul-Aug;13(4):383-91 - PubMed
  5. Trends Cell Biol. 2002 Aug;12(8):368-73 - PubMed
  6. Pathol Oncol Res. 1996;2(1-2):48-51 - PubMed
  7. Oncologist. 2004;9(4):361-77 - PubMed
  8. Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W249-52 - PubMed
  9. Genes Chromosomes Cancer. 1990 Nov;2(4):278-89 - PubMed
  10. Cell. 2003 Mar 7;112(5):673-84 - PubMed
  11. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 - PubMed
  12. Genes Dev. 1998 Nov 1;12(21):3337-42 - PubMed
  13. Bull Cancer. 1994 Feb;81(2):108-13 - PubMed
  14. Breast Cancer Res Treat. 2004 Nov;88(2):177-86 - PubMed

Publication Types